CCM
TBIO

CAAS Capital Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

CAAS Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,944
Closed -$390K – 1092
2021
Q3 		$390K Hold
1,944
– – 0.01% 665
2021
Q2 		$770K Buy
+1,944
New +$687K 0.01% 650

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CAAS Capital Management's TBIO Position: Q4 2021 in Review

CAAS Capital Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2021, closing a stake of 1,944 shares — an estimated $390K sold.

CAAS Capital Management first reported a position in TBIO in Q2 2021 and held it in 2 quarters. The position peaked at $770K in Q2 2021. 43 funds tracked by Wall St. Rank hold TBIO as of Q4 2021.

  • CAAS Capital Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • CAAS Capital Management sold 1,944 Telesis Bio, Inc. Common Stock shares in Q4 2021, an estimated $390K.
  • CAAS Capital Management first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • CAAS Capital Management's Telesis Bio, Inc. Common Stock position peaked at $770K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2021.

Based on CAAS Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.